Krka established its representative office in Kyrgyzstan in 2010, when it has already been present in the country with its products. Our representative office has been developing dynamically and today employs highly qualified and motivated staff. We pursue our common goal of living a healthy life by working together with healthcare professionals and institutions.
We have always been focused on providing advanced products: our antihypertensive medicine Lorista (losartan) and Atoris (atorvastatin) from our statin family are among the most notable products in the country. We have been steadily expanding our product portfolio with new medicines for the treatment of most common diseases of our time, namely cardiovascular diseases and diseases of the gastrointestinal tract, to meet market needs. Vitamins and minerals are also constantly added to our product range. This means that affordable and high-quality therapy, which meets high European standards, and new approaches to treatment are available to patients in Kyrgyzstan.
Krka has been a great supporter of major scientific and educational conferences and seminars in the country. Educational symposiums for healthcare professionals are also organised in-house together with prominent experts from Kyrgyzstan and our neighbouring countries.
With its prescription pharmaceuticals and non-prescription products, Krka has earned itself a spot among leading pharmaceutical companies in Kyrgyzstan. Medical experts and patients see an innovative pharmaceutical company and a trustworthy partner in us.